BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NAB2, MADER, 4665, ENSG00000166886, Q15742, MGC75085 AND Treatment
7 results:

  • 1. Analysis of the current state of cervical cancer prevention awareness and its influencing factors among rural women in Luohe City.
    Zhang Q; Zhang W; Xu T; Song J; Li S; Zhang H; Fu X
    Medicine (Baltimore); 2024 Feb; 103(7):e35136. PubMed ID: 38363922
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sarcoma care in the era of precision medicine.
    Wallander K; Öfverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; Haglund de Flon F
    J Intern Med; 2023 Dec; 294(6):690-707. PubMed ID: 37643281
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Experiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for cancer Clinical Trials.
    Medina SP; Zhang S; Nieves E; Dornsife DL; Johnson R; Spicer D; Borno HT
    JCO Oncol Pract; 2023 May; 19(5):e801-e810. PubMed ID: 36800640
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.
    Zheng Q; Xia W; Lu Q; Hong R; Qin G; Xu F; Qin T; Shi Y; Yuan Z; Wang S
    Breast Cancer Res Treat; 2016 Nov; 160(2):197-209. PubMed ID: 27663434
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.
    Madaras L; Baranyák Z; Kulka J; Szász AM; Kovács A; Lan PH; Székely B; Dank M; Nagy T; Kiss O; Harsányi L; Barbai T; Kenessey I; Tőkés AM
    Pathol Oncol Res; 2013 Oct; 19(4):723-9. PubMed ID: 23709114
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
    Gianni L; Eiermann W; Semiglazov V; Manikhas A; Lluch A; Tjulandin S; Zambetti M; Vazquez F; Byakhow M; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Baronio R; Feyereislova A; Barton C; Valagussa P; Baselga J
    Lancet; 2010 Jan; 375(9712):377-84. PubMed ID: 20113825
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment.
    Stockton D; Davies T; Day N; McCann J
    BMJ; 1997 Feb; 314(7079):472-5. PubMed ID: 9056796
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.